BioNTech SE

ISIN US09075V1026

 | 

Code du titre A2PSR2

Cap. boursière (en EUR)
22 272 M
Country
Allemagne
Secteur
Santé
Rendement en dividendes
0,00%
 

Aperçu

Cours actuel

Description

BioNTech SE est une société d'immunothérapie qui propose des thérapies pour le cancer et d'autres maladies graves. Son portefeuille de produits comprend BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs et Next-Gen CP Immunomodulators. La société a été fondée par Christopher Huber, Oezlem Tuereci et Ugur Sahin le 2 juin 2008 et son siège social se trouve à Mayence, en Allemagne.
Afficher plus Afficher moins
Santé Produits biopharmaceutiques Produits biopharmaceutiques non systémiques Allemagne

Graphique

Données financières

Indicateurs clés

Capitalisation boursière, EUR 22 272 M
BPA, EUR -2,38
Ratio cours/valeur comptable 1,2
PER 159,5
Rendement en dividendes 0,00%

Compte de résultat (2024)

Chiffre d'affaires, EUR 2 751 M
Résultat net, EUR -665 M
Marge bénéficiaire -24,18%

Quel ETF contient BioNTech SE ?

Il y a 4 ETF qui contiennent BioNTech SE. Tous ces ETF sont énumérés dans le tableau ci-dessous. L’ETF ayant la plus grande pondération de BioNTech SE est le iShares Nasdaq US Biotechnology UCITS ETF USD (Dist).
ETF Weight Investment focus Fund size (in m EUR)
iShares STOXX Europe Equity Multifactor UCITS ETF EUR (Dist) 0,09%
Actions
Europe
Stratégie multi-facteurs
181
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) 0,81%
Actions
États-Unis
Santé
Biotechnologie
46
Amundi Prime Eurozone UCITS ETF DR (D) 0,14%
Actions
Europe
57
Amundi Prime Europe UCITS ETF DR (D) 0,07%
Actions
Europe
215

Performance

Returns overview

YTD +9.72%
1 month -3.25%
3 months -0.56%
6 months -7.49%
1 year -21.36%
3 years -33.25%
5 years -8.18%
Since inception (MAX) +615.73%
2025 -24.98%
2024 +13.87%
2023 -33.67%
2022 -33.06%

Monthly returns in a heat map

Risk

Risk metrics in this section:
 
  • Volatility, annualised, measured for 1, 3 and 5 year periods. The annualised volatility reflects the degree of price fluctuations during a one year period. The higher the volatility, the more significantly the price of the asset (stock, ETF, etc.) has changed in the past. Assets with higher volatility are generally considered more risky. We calculate the volatility based on the data for the past 1, 3 and 5 years so that you can see if price fluctuations for the ETF became stronger or weaker over time.
  • Return per risk for 1, 3 and 5 year periods. This is the annualised (i.e. converted to a one year period) past return divided by the past annualised volatility. The metric puts the historical return of an asset in relation to its historical risk and gives you a retrospective indication of the degree of price fluctuation you had to bear with in order to obtain the return. We calculate this parameter for 1, 3 and 5 year periods to display its evolution over time.
  • Maximum drawdown for a period. This shows the worst possible loss an investor could have suffered during the respective period, by first buying and subsequently selling the asset at the least favourable prices. For example, if there was the following sequence of daily ETF prices: 10€, 5€, 12€, 20€, an investor would have suffered the worst loss by buying for 10€ and subsequently selling for 5€. Therefore in this case the maximum drawdown would be (5€ - 10€)/10€ = -50%.
ETF returns include dividend payments (if applicable).
Show more Show less

Risk overview

Volatility 1 year 45.62%
Volatility 3 years 41.47%
Volatility 5 years 54.22%
Return per risk 1 year -0.47
Return per risk 3 years -0.30
Return per risk 5 years -0.03
Maximum drawdown 1 year -33.63%
Maximum drawdown 3 years -48.10%
Maximum drawdown 5 years -81.14%
Maximum drawdown since inception -81.14%

Rolling 1 year volatility

— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.